{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:40:10Z","timestamp":1783975210590,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2304100"],"award-info":[{"award-number":["2022YFC2304100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.antiviral.2026.106403","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:11:32Z","timestamp":1775315492000},"page":"106403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Salinomycin inhibits orthopoxvirus infection in vitro and in vivo by blocking endosomal acidification"],"prefix":"10.1016","volume":"249","author":[{"given":"Congcong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4090-8852","authenticated-orcid":false,"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-326X","authenticated-orcid":false,"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106403_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."},{"key":"10.1016\/j.antiviral.2026.106403_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamadermatol.2023.4727","article-title":"Successful treatment of recalcitrant mpox lesions with intralesional cidofovir in a patient with HIV\/AIDS","volume":"160","author":"Buechler","year":"2024","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.antiviral.2026.106403_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105182","article-title":"Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. food and drug Administration's evaluation","volume":"195","author":"Chan-Tack","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106403_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102528","article-title":"Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf","volume":"52","author":"De Clercq","year":"2023","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106403_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108959","article-title":"Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2","volume":"35","author":"Dittmar","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2026.106403_bib7","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3390\/ijms26062718","article-title":"Antiviral effects of tecovirimat and cellular ultrastructural changes in human bronchial epithelial cell line following monkeypox virus infection","volume":"26","author":"Falasca","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2026.106403_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.hlife.2025.03.003","article-title":"Modeling the pathogenic infection of mpox virus clade IIb in type I and II interferon pathway double deficient mice","volume":"3","author":"Fan","year":"2025","journal-title":"hLife"},{"key":"10.1016\/j.antiviral.2026.106403_bib9","article-title":"Identification of tecovirimat resistance-associated mutations in Human Monkeypox virus - los Angeles county","volume":"67","author":"Garrigues","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106403_bib10","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"Gessain","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106403_bib11","article-title":"Targeting virus-interacting host ion channels as a novel antiviral strategy","author":"Guo","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.antiviral.2026.106403_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2026.106403_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s40265-018-0967-6","article-title":"Tecovirimat: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2026.106403_bib14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/acscentsci.8b00257","article-title":"The molecular basis for inhibition of stemlike cancer cells by Salinomycin","volume":"4","author":"Huang","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.antiviral.2026.106403_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79897-9","article-title":"Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions","volume":"14","author":"Imani","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106403_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01441-18","article-title":"Salinomycin inhibits influenza virus infection by disrupting endosomal acidification and viral matrix protein 2 function","volume":"92","author":"Jang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106403_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095970","article-title":"Inhibition of autophagic flux by Salinomycin results in anti-cancer effect in hepatocellular carcinoma cells","volume":"9","author":"Klose","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106403_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002446","article-title":"The membrane fusion step of Vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components","volume":"7","author":"Laliberte","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106403_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29536","article-title":"Prolonged viral shedding in an immunocompromised Korean patient infected with hMPXV, sub-lineage B.1.3, with acquired drug resistant mutations during tecovirimat treatment","volume":"96","author":"Lee","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106403_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.csbj.2021.04.001","article-title":"Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification","volume":"19","author":"Li","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.antiviral.2026.106403_bib21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2026.106403_bib22","doi-asserted-by":"crossref","first-page":"7056","DOI":"10.1038\/s41467-025-62064-7","article-title":"Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC","volume":"16","author":"Masirika","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2026.106403_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01207","article-title":"Investigating different mechanisms of action in combination therapy for influenza","volume":"9","author":"Melville","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.antiviral.2026.106403_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.15585\/mmwr.mm7422a2","article-title":"Clade Ib Mpox outbreak - kenya, July 2024-February 2025","volume":"74","author":"Mutuku","year":"2025","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2026.106403_bib25","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMoa2412439","article-title":"Tecovirimat for clade I MPXV infection in the democratic republic of Congo","volume":"392","author":"null","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106403_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105995","article-title":"Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates","volume":"231","author":"Pr\u00e9vost","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106403_bib27","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7209a4","article-title":"Interim clinical treatment considerations for severe manifestations of mpox \u2014 united States, February 2023","volume":"72","author":"Rao","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2026.106403_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2023.184182","article-title":"Selectivity of cation transport across lipid membranes by the antibiotic salinomycin","volume":"1865","author":"Rokitskaya","year":"2023","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2026.106403_bib29","doi-asserted-by":"crossref","unstructured":"A.T. Russo, D.W. Grosenbach, J. Chinsangaram, K.M. Honeychurch, P.G. Long, C. Lovejoy, B. Maiti, I. Meara, D.E. Hruby, An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications, Expert Rev. Anti Infect. Ther. 19 (n.d.) 331\u2013344. https:\/\/doi.org\/10.1080\/14787210.2020.1819791.","DOI":"10.1080\/14787210.2020.1819791"},{"key":"10.1016\/j.antiviral.2026.106403_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries \u2014 April\u2013June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106403_bib31","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review","volume":"332","author":"Titanji","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2026.106403_bib32","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1128\/JVI.00606-07","article-title":"Two distinct Low-pH steps promote entry of Vaccinia virus","volume":"81","author":"Townsley","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106403_bib33","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1128\/JVI.01053-06","article-title":"Vaccinia virus entry into cells via a low-ph-dependent endosomal pathway","volume":"80","author":"Townsley","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106403_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jpids\/pix011","article-title":"Renal toxicity in pediatric patients receiving cidofovir for the treatment of adenovirus infection","volume":"6","author":"Vora","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.antiviral.2026.106403_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.imj.2023.05.004","article-title":"Animal models of mpox virus infection and disease","volume":"2","author":"Wei","year":"2023","journal-title":"Infect Med (Beijing)"},{"key":"10.1016\/j.antiviral.2026.106403_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.virol.2008.12.029","article-title":"Vaccinia virus exhibits cell-type-dependent entry characteristics","volume":"385","author":"Whitbeck","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2026.106403_bib37","unstructured":"WHO director-general declares the ongoing monkeypox outbreak a public health emergency of international concern, (n.d.). https:\/\/www.who.int\/europe\/news\/item\/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern (accessed November 9, 2025)."},{"key":"10.1016\/j.antiviral.2026.106403_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132231","article-title":"Structural basis of human mpox viral DNA replication inhibition by brincidofovir and cidofovir","volume":"270","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.antiviral.2026.106403_bib39","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106403_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102940","article-title":"Mpox infection: a state-of-the-art overview of epidemiological, molecular, and clinical aspects following the 2024 public health emergency","volume":"18","author":"Zamani","year":"2025","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.antiviral.2026.106403_bib41","article-title":"MPXV infection activates cGAS-STING signaling and IFN-I treatment reduces pathogenicity of mpox in CAST\/EiJ mice and rhesus macaques","volume":"6","author":"Zhu","year":"2025","journal-title":"Cell Rep. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:47:49Z","timestamp":1779511669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S0166354226000628"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106403","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salinomycin inhibits orthopoxvirus infection in vitro and in vivo by blocking endosomal acidification","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106403"}}